Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Drake

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Postgraduate Medical Journal|March 14, 1998
Right atrial thrombus from deep venous thrombosisW M Drake, R S More
Lancet (London, England)|February 12, 1994
Heart block in a patient on propranolol and fluoxetineW M Drake, G D Gordon
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 1, 1996
QT-interval prolongation with EcstasyW M Drake, P A Broadhurst
Annales D'Endocrinologie|March 18, 2020
Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemiaC E Stiles, R P Steeds, W M Drake
Clinical Therapeutics|May 17, 2001
Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000W M Drake, D L Kendler, J P Brown
European Journal of Endocrinology|August 19, 2008
Clinical use of cabergoline as primary and adjunctive treatment for acromegalyV J Moyes, K A Metcalfe, W M Drake
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patientsW M Drake, M P Hiorns, D L Kendler
European Journal of Endocrinology|March 15, 2005
Effect of treatment with pegvisomant on meningioma growth in vivoW M Drake, A B Grossman, R K Hutson
Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Clinical use of a growth hormone receptor antagonist in the treatment of acromegalyW M Drake, C Parkinson, G M Besser, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 7, 2002
Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal womenW M Drake, J P Brown, C Banville, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Postgraduate Medical Journal|March 14, 1998
Right atrial thrombus from deep venous thrombosisW M Drake, R S More
Lancet (London, England)|February 12, 1994
Heart block in a patient on propranolol and fluoxetineW M Drake, G D Gordon
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 1, 1996
QT-interval prolongation with EcstasyW M Drake, P A Broadhurst
Annales D'Endocrinologie|March 18, 2020
Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemiaC E Stiles, R P Steeds, W M Drake
Clinical Therapeutics|May 17, 2001
Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000W M Drake, D L Kendler, J P Brown
European Journal of Endocrinology|August 19, 2008
Clinical use of cabergoline as primary and adjunctive treatment for acromegalyV J Moyes, K A Metcalfe, W M Drake
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patientsW M Drake, M P Hiorns, D L Kendler
European Journal of Endocrinology|March 15, 2005
Effect of treatment with pegvisomant on meningioma growth in vivoW M Drake, A B Grossman, R K Hutson
Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Clinical use of a growth hormone receptor antagonist in the treatment of acromegalyW M Drake, C Parkinson, G M Besser, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 7, 2002
Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal womenW M Drake, J P Brown, C Banville, et al.
Pageof 9